These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 14769253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 3. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M.
    J Pharm Pharm Sci; 2005 Jan 12; 8(1):18-25. PubMed ID: 15946594
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET, Cadé D, Benameur H.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):747-56. PubMed ID: 18096270
    [Abstract] [Full Text] [Related]

  • 7. Formulation of spray congealed microparticles with self-emulsifying ability for enhanced glibenclamide dissolution performance.
    Albertini B, Sabatino MD, Melegari C, Passerini N.
    J Microencapsul; 2015 Mar 17; 32(2):181-92. PubMed ID: 25423165
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid fill hard gelatin capsules.
    Rowley G, Hawley AR, Dobson CL, Chatham S.
    Drug Dev Ind Pharm; 1998 Jul 17; 24(7):605-11. PubMed ID: 9876504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance.
    Schamp K, Schreder SA, Dressman J.
    Eur J Pharm Biopharm; 2006 Apr 17; 62(3):227-34. PubMed ID: 16246538
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Understanding the degradation pathway of a poorly water-soluble drug formulated in PEG-400.
    Kochling JD, Miao H, Young CR, Looker AR, Shannon M, Montgomery ER.
    J Pharm Biomed Anal; 2007 Apr 11; 43(5):1638-46. PubMed ID: 17224256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M.
    Biopharm Drug Dispos; 2004 Mar 11; 25(2):91-8. PubMed ID: 14872557
    [Abstract] [Full Text] [Related]

  • 20. Development and evaluation of an ideal formulation of glibenclamide by solid dispersion techniques.
    Ghosh LK, Thakur RS, Sharma PK, Ghosh NC, Gupta BK.
    Boll Chim Farm; 1998 Jan 11; 137(1):26-9. PubMed ID: 9595831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.